750 related articles for article (PubMed ID: 33583034)
1. Higher vs lower doses of dexamethasone in patients with COVID-19 and severe hypoxia (COVID STEROID 2) trial: Protocol and statistical analysis plan.
Munch MW; Granholm A; Myatra SN; Vijayaraghavan B; Cronhjort M; Wahlin RR; Jakob SM; Cioccari L; Kjaer MN; Vesterlund GK; Meyhoff TS; Helleberg M; Møller MH; Benfield T; Venkatesh B; Hammond N; Micallef S; Bassi A; John O; Jha V; Kristiansen KT; Ulrik CS; Jørgensen VL; Smitt M; Bestle MH; Andreasen AS; Poulsen LM; Rasmussen BS; Brøchner AC; Strøm T; Møller A; Khan MS; Padmanaban A; Divatia JV; Saseedharan S; Borawake K; Kapadia F; Dixit S; Chawla R; Shukla U; Amin P; Chew MS; Gluud C; Lange T; Perner A
Acta Anaesthesiol Scand; 2021 Jul; 65(6):834-845. PubMed ID: 33583034
[TBL] [Abstract][Full Text] [Related]
2. Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia (COVID STEROID) trial-Protocol and statistical analysis plan.
Petersen MW; Meyhoff TS; Helleberg M; Kjaer MN; Granholm A; Hjortsø CJS; Jensen TS; Møller MH; Hjortrup PB; Wetterslev M; Vesterlund GK; Russell L; Jørgensen VL; Tjelle K; Benfield T; Ulrik CS; Andreasen AS; Mohr T; Bestle MH; Poulsen LM; Hitz MF; Hildebrandt T; Knudsen LS; Møller A; Sølling CG; Brøchner AC; Rasmussen BS; Nielsen H; Christensen S; Strøm T; Cronhjort M; Wahlin RR; Jakob S; Cioccari L; Venkatesh B; Hammond N; Jha V; Myatra SN; Gluud C; Lange T; Perner A
Acta Anaesthesiol Scand; 2020 Oct; 64(9):1365-1375. PubMed ID: 32779728
[TBL] [Abstract][Full Text] [Related]
3. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
4. Effect of 12 mg vs 6 mg of Dexamethasone on the Number of Days Alive Without Life Support in Adults With COVID-19 and Severe Hypoxemia: The COVID STEROID 2 Randomized Trial.
; Munch MW; Myatra SN; Vijayaraghavan BKT; Saseedharan S; Benfield T; Wahlin RR; Rasmussen BS; Andreasen AS; Poulsen LM; Cioccari L; Khan MS; Kapadia F; Divatia JV; Brøchner AC; Bestle MH; Helleberg M; Michelsen J; Padmanaban A; Bose N; Møller A; Borawake K; Kristiansen KT; Shukla U; Chew MS; Dixit S; Ulrik CS; Amin PR; Chawla R; Wamberg CA; Shah MS; Darfelt IS; Jørgensen VL; Smitt M; Granholm A; Kjær MN; Møller MH; Meyhoff TS; Vesterlund GK; Hammond NE; Micallef S; Bassi A; John O; Jha A; Cronhjort M; Jakob SM; Gluud C; Lange T; Kadam V; Marcussen KV; Hollenberg J; Hedman A; Nielsen H; Schjørring OL; Jensen MQ; Leistner JW; Jonassen TB; Kristensen CM; Clapp EC; Hjortsø CJS; Jensen TS; Halstad LS; Bak ERB; Zaabalawi R; Metcalf-Clausen M; Abdi S; Hatley EV; Aksnes TS; Gleipner-Andersen E; Alarcón AF; Yamin G; Heymowski A; Berggren A; La Cour K; Weihe S; Pind AH; Engstrøm J; Jha V; Venkatesh B; Perner A
JAMA; 2021 Nov; 326(18):1807-1817. PubMed ID: 34673895
[TBL] [Abstract][Full Text] [Related]
5. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
[TBL] [Abstract][Full Text] [Related]
6. Higher vs Lower Doses of Dexamethasone in Patients with COVID-19 and Severe Hypoxia (COVID STEROID 2) trial: Protocol for a secondary Bayesian analysis.
Granholm A; Munch MW; Myatra SN; Vijayaraghavan BKT; Cronhjort M; Wahlin RR; Jakob SM; Cioccari L; Kjaer MN; Vesterlund GK; Meyhoff TS; Helleberg M; Møller MH; Benfield T; Venkatesh B; Hammond N; Micallef S; Bassi A; John O; Jha V; Kristiansen KT; Ulrik CS; Jørgensen VL; Smitt M; Bestle MH; Andreasen AS; Poulsen LM; Rasmussen BS; Brøchner AC; Strøm T; Møller A; Khan MS; Padmanaban A; Divatia JV; Saseedharan S; Borawake K; Kapadia F; Dixit S; Chawla R; Shukla U; Amin P; Chew MS; Gluud C; Lange T; Perner A
Acta Anaesthesiol Scand; 2021 May; 65(5):702-710. PubMed ID: 33583027
[TBL] [Abstract][Full Text] [Related]
7. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
8. Proactive Prophylaxis With Azithromycin and HydroxyChloroquine in Hospitalised Patients With COVID-19 (ProPAC-COVID): A structured summary of a study protocol for a randomised controlled trial.
Sivapalan P; Ulrik CS; Bojesen RD; Lapperre TS; Eklöf JV; Håkansson KEJ; Browatzki A; Tidemansen C; Wilcke JT; Janner J; Gottlieb V; Meteran H; Porsbjerg C; Madsen BL; Moberg M; Pedersen L; Benfield TL; Lundgren JD; Knop FK; Biering-Sørensen T; Ghanizada M; Sonne TP; Bødtger UCS; Jensen SG; Rasmussen DB; Brøndum E; Tupper OD; Sørensen SW; Alstrup G; Laursen CB; Møller UW; Sverrild A; Jensen JS
Trials; 2020 Jun; 21(1):513. PubMed ID: 32522282
[TBL] [Abstract][Full Text] [Related]
9. Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial.
Garcia-Vicuña R; Abad-Santos F; González-Alvaro I; Ramos-Lima F; Sanz JS
Trials; 2020 Sep; 21(1):772. PubMed ID: 32907638
[TBL] [Abstract][Full Text] [Related]
10. Low-dose hydrocortisone in patients with COVID-19 and severe hypoxia: The COVID STEROID randomised, placebo-controlled trial.
Munch MW; Meyhoff TS; Helleberg M; Kjaer MN; Granholm A; Hjortsø CJS; Jensen TS; Møller MH; Hjortrup PB; Wetterslev M; Vesterlund GK; Russell L; Jørgensen VL; Kristiansen KT; Benfield T; Ulrik CS; Andreasen AS; Bestle MH; Poulsen LM; Hildebrandt T; Knudsen LS; Møller A; Sølling CG; Brøchner AC; Rasmussen BS; Nielsen H; Christensen S; Strøm T; Cronhjort M; Wahlin RR; Jakob SM; Cioccari L; Venkatesh B; Hammond N; Jha V; Myatra SN; Jensen MQ; Leistner JW; Mikkelsen VS; Svenningsen JS; Laursen SB; Hatley EV; Kristensen CM; Al-Alak A; Clapp E; Jonassen TB; Bjerregaard CL; Østerby NCH; Jespersen MM; Abou-Kassem D; Lassen ML; Zaabalawi R; Daoud MM; Abdi S; Meier N; la Cour K; Derby CB; Damlund BR; Laigaard J; Andersen LL; Mikkelsen J; Jensen JLS; Rasmussen AH; Arnerlöv E; Lykke M; Holst-Hansen MZB; Tøstesen BW; Schwab J; Madsen EK; Gluud C; Lange T; Perner A
Acta Anaesthesiol Scand; 2021 Nov; 65(10):1421-1430. PubMed ID: 34138478
[TBL] [Abstract][Full Text] [Related]
11. A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial.
Rilinger J; Kern WV; Duerschmied D; Supady A; Bode C; Staudacher DL; Wengenmayer T
Trials; 2020 Jun; 21(1):470. PubMed ID: 32493514
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19).
Urwyler P; Charitos P; Moser S; Heijnen IAFM; Trendelenburg M; Thoma R; Sumer J; Camacho-Ortiz A; Bacci MR; Huber LC; Stüssi-Helbling M; Albrich WC; Sendi P; Osthoff M
Trials; 2021 Jan; 22(1):1. PubMed ID: 33397449
[TBL] [Abstract][Full Text] [Related]
13. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
[TBL] [Abstract][Full Text] [Related]
14. Sarilumab versus standard of care for the early treatment of COVID-19 pneumonia in hospitalized patients: SARTRE: a structured summary of a study protocol for a randomised controlled trial.
Caballero Bermejo AF; Ruiz-Antorán B; Fernández Cruz A; Diago Sempere E; Callejas Díaz A; Múñez Rubio E; Avendaño-Solá C; Ramos Martínez A; Sancho López A;
Trials; 2020 Sep; 21(1):794. PubMed ID: 32938496
[TBL] [Abstract][Full Text] [Related]
15. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
[TBL] [Abstract][Full Text] [Related]
16. Dexamethasone doses in patients with COVID-19 and hypoxia: A systematic review and meta-analysis.
Munch MW; Granholm A; Maláska J; Stašek J; Rodriguez PO; Pitre T; Wilson R; Savović J; Rochwerg B; Svobodnik A; Kratochvíl M; Taboada M; Jha V; Vijayaraghavan BKT; Myatra SN; Venkatesh B; Perner A; Møller MH
Acta Anaesthesiol Scand; 2024 Feb; 68(2):146-166. PubMed ID: 37881881
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
18. Effect of dexamethasone in patients with ARDS and COVID-19 (REMED trial)-study protocol for a prospective, multi-centre, open-label, parallel-group, randomized controlled trial.
Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
Trials; 2022 Jan; 23(1):35. PubMed ID: 35033182
[TBL] [Abstract][Full Text] [Related]
19. Systemic corticosteroids for the treatment of COVID-19.
Wagner C; Griesel M; Mikolajewska A; Mueller A; Nothacker M; Kley K; Metzendorf MI; Fischer AL; Kopp M; Stegemann M; Skoetz N; Fichtner F
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD014963. PubMed ID: 34396514
[TBL] [Abstract][Full Text] [Related]
20. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
